Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Neonatal Seizures
NCT07401433Completed
- Sponsor
- Hayatabad Medical Complex
- Start
- Apr 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levetiracetam in neonatal seizures (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Seizure Cessation Within 40 Minutes. Started Apr 2024; status: completed.
02
Drugs
levetiracetam
03
Conditions
neonatal seizures
Beyond the preview
Go deeper on NCT07401433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401433.